BioSpace News Archive

Natural Alternatives International, Inc., a leading formulator, and marketer of customized nutritional supplements announced that the U.S. Court of Appeals for the Federal Circuit has ruled in NAI’s favor, holding that its CarnoSyn® beta-alanine patents are “patent eligible” under existing law.

The U.S. Food and Drug Administration issued warning letters to two breast implant manufacturers for failure to comply with their requirements, under their premarket approval orders, to conduct post-approval studies to assess the long-term safety and risks of their silicone gel-filled breast implants.

Addition of Deep Industry Knowledge, Operating Expertise to be Keys to Northpoint’s Growth

Leading Independent Clinical Research Site Company Appoints Chastain and Greene to Executive Management Team

Provention Bio, Inc. reported financial results for the fourth quarter and full year ended December 31, 2018 and provided a business update.

BioData has announced The Netherlands Cancer Institute (NKI) has started an institute wide deployment of its flagship product Labguru.

Nevro Corp. (NYSE: NVRO) (“Nevro”), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman has been appointed President and Chief Executive Officer of Nevro and a member of the Board of Directors (the “Board”), effective today.

Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotechnology acceleration development company, announced today that its technology partner Mannin Research Inc. has entered into a research collaboration with the Biointerfaces Institute at McMaster University in Ontario, Canada to develop a GDF15 biomarker diagnostic kit for monitoring glaucoma severity and progression.

Rho, a full-service contract research organization (CRO), is hiring for a variety of clinical research positions and will be looking to meet potential applicants during the upcoming Outsourcing in Clinical Trials Southeast 2019 conference in Durham, North Carolina – close to Rho’s headquarters in Chapel Hill – March 26 and 27.

CRF Bracket announced a new release of TrialConsent®, the latest version of its revolutionary eConsent solution, with enhanced capabilities to support remote consenting in virtual clinical trials.